GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sensorion SA (XPAR:ALSEN) » Definitions » Float Percentage Of Total Shares Outstanding

Sensorion (XPAR:ALSEN) Float Percentage Of Total Shares Outstanding : 0.00% (As of Jun. 04, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Sensorion Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Sensorion's float shares is 0.00 Mil. Sensorion's total shares outstanding is 300.12 Mil. Sensorion's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Sensorion's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Sensorion's Institutional Ownership is 2.10%.

Sensorion Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Sensorion's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/300.12
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sensorion (XPAR:ALSEN) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sensorion SA (XPAR:ALSEN) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
XPAR:ADOC XPAR:OSE XPAR:TNG XPAR:MAAT XPAR:GNFT XPAR:ALVAL XPAR:MEDCL XPAR:AELIS XPAR:ALCLS XPAR:IVA OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
RFM:Germany
Address
375, rue du Professeur Joseph Blayac, Montpellier, FRA, 34080
Website
https://www.sensorion.com/en
Sensorion SA is a France-based clinical-stage biotech company dedicated to the development of therapies to restore, treat and prevent hearing loss. The company's product is in phase 2 clinical development, SENS-401 (Arazasetron) in Sudden Sensorineural Hearing Loss (SSNHL). SENS-401 is being developed to treat cochlear pathologies.

Sensorion (XPAR:ALSEN) Headlines

No Headlines